How to book a medical appointment in Shanghai?

You can book through our online form, email, WeChat, or live chat. We will arrange the appointment within 24 hours and provide full assistance throughout your medical journey.

What languages do you support?

We provide full support in English, Russian, Chinese, Korean, and Japanese. All medical translations are handled by professional medical interpreters.

What are the payment methods?

Medical fees are paid directly to the hospital. Service fees can be paid via bank transfer, WeChat Pay, Alipay, or international wire transfer.

Do you help with visa arrangements?

Yes, we provide complete visa guidance and invitation letters for medical tourism to China.

Which hospitals do you partner with?

We partner with top-tier hospitals in Shanghai including Jiahui International Hospital, Huashan Hospital, Ruijin Hospital, and other leading medical institutions.

Gastric Cancer Treatment in Shanghai: 2026 International Patient Guide

Why Shanghai for Gastric Cancer

China has one of the world's highest gastric cancer incidence rates, giving Shanghai surgeons extraordinary case volume and experience — particularly in laparoscopic and robotic gastrectomy, D2 lymph node dissection, and hyperthermic intraperitoneal chemotherapy (HIPEC).

Top Hospitals

Ruijin Hospital, SJTU — Leading minimally invasive gastrectomy program; Prof. Zang Lu (臧潞) specializes in laparoscopic surgery and conversion therapy.

Fudan University Shanghai Cancer Center (FUSCC) — Prof. Liu Xiaowen (刘晓文), robotic surgery and perioperative immunotherapy.

Shanghai General Hospital — Comprehensive GI oncology with international training background.

Yueyang Hospital — Integrated TCM-WM gastric cancer program including HIPEC.

Treatment Approach

Early gastric cancer: Endoscopic submucosal dissection (ESD) at selected centers; minimally invasive D2 gastrectomy.

Locally advanced: Perioperative FLOT or SOX/XELOX chemotherapy; laparoscopic or robotic D2 gastrectomy.

Advanced/metastatic: Immunotherapy (nivolumab, pembrolizumab, sintilimab) combined with chemotherapy; HER2+ cases receive trastuzumab; CLDN18.2 CAR-T is in clinical trials.

What to Bring

Endoscopy and biopsy pathology report/slides

Contrast-enhanced CT of chest/abdomen/pelvis

HER2, PD-L1, MSI/MMR testing results

Prior treatment records

Cost Reference

Laparoscopic D2 gastrectomy: ¥80,000–130,000. Perioperative chemotherapy: ¥10,000–40,000/cycle. Immunotherapy: ¥10,000–30,000/month depending on agent (Chinese PD-1 inhibitors are much more affordable).